The Covid trade is out. Investors have piled into bets against Novavax, the struggling vaccine developer that was late to ...

With a new booster available, it’s time to look at whether switching up your shots makes a difference in your immunity.

Summary Novavax, Inc. stock has been facing a downward spiral, but there may be a short-term trading opportunity if FDA ...

First, a bit of background. Novavax and Moderna both were early leaders in coronavirus vaccine development, but Novavax fell ...

As a result, Novavax lost out on the biggest revenue opportunity, and its shares have been on the decline ever since. Still, ...

The European Medicines Agency (EMA) expects to decide on the use of Novavax's updated COVID-19 vaccine in October, its ...

Nuvaxovid has been developed under the same principle used in hepatitis B and whooping cough vaccines. The World Health Organization (WHO) has issued an emergency approval for the Novavax drug ...

Novavax received shipments of millions of doses of its updated Covid-19 vaccine this week but can't distribute them until the ...

The stock price of Novavax Inc. (NASDAQ: NVAX) has surged by 4.70 when compared to previous closing price of 6.81, but the company has seen a -7.52% decline in its stock price over the last five ...

Novavax, Inc. stock has been facing a downward spiral, but there may be a short-term trading opportunity if FDA approval for its COVID-19 vaccine is positive. The high level of short interest in ...

In fact, this market giant announced something that could impact smaller rival Novavax (NASDAQ: NVAX). Both companies are vying for a share of the post-pandemic vaccine market, and both of them ...